Cellectar Biosciences (CLRB) Short-term Investments (2011 - 2014)
Cellectar Biosciences (CLRB) posted Short-term Investments of $55000.0 for Q4 2014, little changed sequentially from $55000.0 in Q3 2014, and little changed YoY from $55000.0 in Q4 2013.
Cellectar Biosciences (CLRB) Short-term Investments (2011 - 2014) Analysis & Trends
Cellectar Biosciences has reported Short-term Investments for 4 years, with the latest figure at $55000.0 in Q4 2014.
- Quarterly Short-term Investments changed 0.0% year-over-year to $55000.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $55000.0 (changed 0.0% YoY) and the FY2014 annual result came in at $55000.0, changed 0.0% from the prior year.
- Short-term Investments steadied at $55000.0 in Q4 2014 per CLRB's latest filing, from $55000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $55000.0 in Q4 2011 and troughed at $55000.0 in Q4 2011.
- A 4-year average of $55000.0 and a median of $55000.0 in 2011 frame the typical range for Short-term Investments.
- The widest YoY moves for Short-term Investments: up 0.0% in 2012, down 0.0% in 2012.
- Over 4 years, Short-term Investments stood at $55000.0 in 2011, then changed by 0.0% to $55000.0 in 2012, then changed by 0.0% to $55000.0 in 2013, then changed by 0.0% to $55000.0 in 2014.
- According to Business Quant data, Short-term Investments over the past three periods registered $55000.0, $55000.0, and $55000.0 for Q4 2014, Q3 2014, and Q2 2014 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cellectar Biosciences | 6.73 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 55,000.00 |
| Sep 30, 2014 | 55,000.00 |
| Jun 30, 2014 | 55,000.00 |
| Mar 31, 2014 | 55,000.00 |
| Dec 31, 2013 | 55,000.00 |
| Sep 30, 2013 | 55,000.00 |
| Jun 30, 2013 | 55,000.00 |
| Mar 31, 2013 | 55,000.00 |
| Dec 31, 2012 | 55,000.00 |
| Dec 31, 2011 | 55,000.00 |